You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 1, January 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anti-Intercellular Substance Antibodies

Presence in Serum Samples of 14 Patients Without Pemphigus

A. Razzaque Ahmed, MD; Steven Workman, MD

Arch Dermatol. 1983;119(1):17-21.


Abstract

• Fourteen of 1,500 patients whose serum samples were evaluated by indirect immunofluorescence microscopy had demonstrable titers of anti-intercellular substance (ICS) antibodies in the absence of clinical or histologic evidence of pemphigus. The anti-ICS antibodies were absorbed by A and B blood group antigens in nine of the 14 patients. In five patients, the titers of anti-ICS antibodies were unchanged after absorption with blood group substances. All five of these patients had cicatricial or bullous pemphigoid on clinical, histologic, and immunopathologic examination. Clinical pemphigus did not develop in any of the 14 patients on follow-up examinations conducted for three to 18 months. It seems that anti-ICS antibodies can be produced in several clinical conditions in which there is damage to the epidermis. These anti-ICS antibodies may not have any pathogenetic activity in vivo, at least within the time limits defined by our follow-up examinations.

(Arch Dermatol 1983;119:17-21)



Author Affiliations

From the Division of Dermatology, Department of Medicine, UCLA School of Medicine.


Footnotes

Accepted for publication Feb 9, 1982.

Reprint requests to UCLA School of Medicine, CHS 52-121, Los Angeles, CA 90024 (Dr Ahmed).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pitfalls in the performance and interpretation of clinical immunology tests
Lock et al.
J. Clin. Pathol. 2008;61:1236-1242.
ABSTRACT | FULL TEXT  

The Role of Antibody to Human {beta}4 Integrin in Conjunctival Basement Membrane Separation: Possible In Vitro Model for Ocular Cicatricial Pemphigoid
Chan et al.
IOVS 1999;40:2283-2290.
ABSTRACT | FULL TEXT  

Desmoglein 3-ELISA: A Pemphigus Vulgaris-Specific Diagnostic Tool
Lenz et al.
Arch Dermatol 1999;135:143-148.
ABSTRACT | FULL TEXT  

Immune-Mediated Subepithelial Blistering Diseases of Mucous Membranes: Pure Ocular Cicatricial Pemphigoid Is a Unique Clinical and Immunopathological Entity Distinct From Bullous Pemphigoid and Other Subsets Identified by Antigenic Specificity of Autoantibodies
Chan et al.
Arch Dermatol 1993;129:448-455.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.